Showing results (1-10 of 97) with videos related to
Sort By:
Pageof 10
The Annals of Pharmacotherapy|April 1, 1995
Torsemide: a pyridine-sulfonylurea loop diureticJ S Blose, K F Adams, J H PattersonPharmacotherapy|March 1, 1996
Pathophysiology of heart failure: changing perceptionsJ H Patterson, K F AdamsMagnesium Research|December 1, 1995
Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new dataC A Sueta, J H Patterson, K F AdamsThe Annals of Pharmacotherapy|October 24, 1997
The AHCPR clinical practice guideline for heart failure revisitedK F Adams, M L Ellis, K M Williamson, et al.Journal of the American College of Cardiology|September 19, 1998
Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting EnzymeJ B Young, M Gheorghiade, B F Uretsky, et al.Pharmacotherapy|September 1, 1994
Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators GroupJ H Patterson, K F Adams, M M Applefeld, et al.Clinical Pharmacology and Therapeutics|April 29, 1998
Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteersK M Williamson, J H Patterson, R H McQueen, et al.American Heart Journal|June 1, 1991
Propranolol therapy alters estimation of potential cardiovascular risk derived from submaximal postinfarction exercise testingJ L Curtis, J L Houghton, J H Patterson, et al.American Heart Journal|March 20, 1998
Clinical predictors of worsening heart failure during withdrawal from digoxin therapyK F Adams, M Gheorghiade, B F Uretsky, et al.Pageof 10